US5071436A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Substitute bony matrix products promoting osteogenesis
Assignee: BASF Beauty Care Solutions France SAS
•
Filing: 1991-05-14
•
Granted: 1991-12-10
•
Expires: 2011-05-14
Abstract
Abstract A new composition is disclosed which serves as a substitute for the bony matrix material present in bones. The new composition includes an association of collagen-hydroxy-apatite and a glycosaminoglycan. The concentration of the hydroxyapatite is preferably 15 to 25% and the concentration of the glycosaminoglycan is between 1 and 2% per liter of 1% collagen gel. The biomaterial product is useful in applications in reconstructive orthopedic surgery as a substitute for natural bone matrix material.
Inventors
- 👤 Alain Huc
- 👤 Roland Allard
- 👤 Jacques Bejui
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 11:39
CPC Classifications
C; C08; C08L; C08L89/00; C08L89/04; C08L89/06; A; A61; A61L; A61L27/00; A61L27/14; A61L27/26; A61L27/40; A61L27/44; A61L27/46; A61L2430/00; A61L2430/02
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
65 words
An osteogenesis-promoting spongy biomaterial for use in a mammalian organism, said material having the ability to facilitate osteogenesis and to take on the mechanical and histological characteristics of bone tissue with time and given spacial requirements, said biomaterial being a composition consisting essentially of glycosaminoglycans bonded to collagen by dehydrothermic reticulation, together with hydroxyapatite so that bonding in said composition is solely by dehydrothermic reticulation.
Claim 2
Dependent Claim
65 words
An osteogenesis-promoting spongy biomaterial for use in a mammalian organism, said material having the ability to facilitate osteogenesis and to take on the mechanical and histological characteristics of bone tissue with time and given spacial requirements, said biomaterial being a composition consisting essentially of glycosaminoglycans bonded to collagen by dehydrothermic reticulation, together with hydroxyapatite so that bonding in said composition is solely by dehydrothermic reticulation.
Claim 3
Dependent Claim
14 words
The osteogenesis-promoting spongy biomaterial defined in claim 1 wherein the collagen is dereticulated collagen.
Claim 4
Dependent Claim
32 words
The osteogenesis-promoting biomateiral defined in claim 1 wherein the concentration of hydroxyapatite is 20 g/l of 1% collagen gel and the concentration of the glycosaminoglycan is 1.6 g/l of 1% collagen gel.
Claim 5
Dependent Claim
13 words
The osteogenesis-promoting biomaterial defined in claim 1 wherein the glycosaminoglycan is acidic chondroitin-4-sulfate.
Claim 6
Dependent Claim
39 words
The osteogenesis-promoting biomaterial defined in claim 1 wherein the collagen is dereticulated collagen, the concentration of hydroxyapatite is 20 g/l of 1% dereticulated collagen gel, and the concentration of the glycosaminoglycan is 1.6 g/l of 1% dereticulated collagen gel.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-12-09 | 1995-06-10 | 1995-12-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-12-09 | 1999-06-10 | 1999-12-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-12-09 | 2003-06-10 | 2003-12-10 | $7700.00 | Window Closed / Lapsed |